Clinical trial
Combination Chemotherapy and Biological Therapy In Treating Patients With Kidney…
NCT00003664 · Cancer Biotherapy Research Group, Other · Unknown status
Key facts
| NCT number | NCT00003664 |
|---|---|
| Title | Combination Chemotherapy and Biological Therapy In Treating Patients With Kidney Cancer That Is Metastatic or Cannot Be Removed Surgically |
| Official title | Combination Chemobiotherapy With Gemcitabine, 5-Fluorouracil, Interleukin-2 and Alpha Interferon in Patients With Metastatic or Unresectable Renal Cell Cancer. A Phase II Study |
| Lead sponsor | Cancer Biotherapy Research Group, Other |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Kidney Cancer |
| Intervention type | Biological, Drug |
| Interventions | aldesleukin, recombinant interferon alfa, fluorouracil, gemcitabine hydrochloride |
| Enrollment | 30 |
| Start date | Oct 1, 1998 |
| First posted | Jul 16, 2004 |
| Last update posted | Nov 6, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: